The MDS Podcast channel was created with the ultimate goal of improving education in Parkinson's disease and other movement disorders, while keeping MDS members, other neurologists, health professionals and neuroscientists updated with novel and clinically-relevant research findings. A monthly issue of the podcast will highlight the results of an article published in the Society journals, Movement Disorders or Movement Disorders Clinical Practice, including an interview with one of the authors of the article selected.
Variability of Movement Disorders: The Influence of Sensation, Action, Cognition, and Emotions
Dr. Matarazzo speaks with Prof. Maja KojoviÄ‡ about the paper awarded as 2021 best review article from the Movement Disorders Journal, highlighting the impact on several factors on the variability of movement disorders.
Perampanel may reduce alpha-synuclein transmission in Parkinson's disease. A possible therapeutic target?Â
Dr. Matarazzo speaks with Prof. Takahashi about the results of his recent study that shows how this anti-epileptic drug may inhibit the transmission of alpha synuclein in PD. While this was tested in animal models, future clinical trials are warranted to test the effects on PD progression.
An interview with Claudia Trenkwalder, MDS President
Dr. Schaefer discusses with Dr. Trenkwalder the 2021 Virtual MDS Congress, her tenure as the MDS president, and her hopes for the future of the MDS.
Blinded RT-QuIC analysis of alpha-synuclein biomarker in skin tissue from Parkinson's disease patients
Dr. Schaefer speaks with Dr. Kanthasamy about RT-QuIC from skin tissues as a potential new biomarker for Parkinson's disease.
Dr. Schaefer speaks with Dr. Olvera about trending videos of tics and other neurological syndromes on social media.
Cognitive and visuospatial abilities in dystonia
Dr. Schaefer speaks with Dr. Camargo about the non-motor and prodromal features of dystonia.